GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Gross Margin %

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Gross Margin % : 77.39% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Cryofocus Medtech (Shanghai) Co's Gross Profit for the six months ended in Jun. 2023 was HK$16.01 Mil. Cryofocus Medtech (Shanghai) Co's Revenue for the six months ended in Jun. 2023 was HK$20.69 Mil. Therefore, Cryofocus Medtech (Shanghai) Co's Gross Margin % for the quarter that ended in Jun. 2023 was 77.39%.


The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's Gross Margin % or its related term are showing as below:

HKSE:06922' s Gross Margin % Range Over the Past 10 Years
Min: 51.24   Med: 69.32   Max: 75.83
Current: 75.83


During the past 4 years, the highest Gross Margin % of Cryofocus Medtech (Shanghai) Co was 75.83%. The lowest was 51.24%. And the median was 69.32%.

HKSE:06922's Gross Margin % is ranked better than
85.02% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 52.83 vs HKSE:06922: 75.83

Cryofocus Medtech (Shanghai) Co had a gross margin of 77.39% for the quarter that ended in Jun. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cryofocus Medtech (Shanghai) Co was 0.00% per year.


Cryofocus Medtech (Shanghai) Co Gross Margin % Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Gross Margin % Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Margin %
51.24 69.32 71.32 75.83

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial - 68.78 72.87 77.39 74.48

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Gross Margin %

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryofocus Medtech (Shanghai) Co's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Gross Margin % falls into.



Cryofocus Medtech (Shanghai) Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Cryofocus Medtech (Shanghai) Co's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=21.6 / 30.318
=(Revenue - Cost of Goods Sold) / Revenue
=(30.318 - 8.696) / 30.318
=71.32 %

Cryofocus Medtech (Shanghai) Co's Gross Margin for the quarter that ended in Jun. 2023 is calculated as


Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=16 / 20.688
=(Revenue - Cost of Goods Sold) / Revenue
=(20.688 - 4.677) / 20.688
=77.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cryofocus Medtech (Shanghai) Co  (HKSE:06922) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cryofocus Medtech (Shanghai) Co had a gross margin of 77.39% for the quarter that ended in Jun. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cryofocus Medtech (Shanghai) Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Traded in Other Exchanges
N/A
Address
Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.
Executives
Wu Jianhui 2101 Beneficial owner
Li Hui 2202 Interest of your spouse
Lv Shiwen 2103 Interests held jointly with another person
Sun Xiaolu 2201 Interest of corporation controlled by you
Zhang Qian
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi He Huo Qi Ye You Xian He Huo
Shang Hai Shi Di Sheng Wu Ke Ji You Xian Gong Si
Shang Hai Bi Lin Xing Zi Chan Guan Li You Xian Gong Si
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Ning Bo Lin Feng Sheng Wu Ke Ji You Xian Gong Si
Shang Hai Shi Di Shi Ye Fa Zhan You Xian Gong Si
Sheng Shan Zi Chan Guan Li Shang Hai You Xian Gong Si
Gan Shi Xiong
Su Zhou Gong Ye Yuan Qu Zhi Nuo Shang Wu Xin Xi Zi Xun You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Xin Jian Yuan Er Qi Chuang Ye Tou Zi Qi Ye You Xian He Huo 2101 Beneficial owner

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines